Cadmium sulfide nanoparticles (CdSNPs) modulate key oncogenic pathways in PA1 ovarian cancer cells: Insights from transcriptomic analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Cadmium Sulfide Nanoparticles (CdSNPs) show therapeutic potential for ovarian cancer by significantly altering gene expression. These nanoparticles activate apoptotic and calcium signaling pathways, inhibiting cancer cell proliferation.
Area Of Science
- Genomics and Molecular Biology
- Nanotechnology in Medicine
- Oncology
Background
- Transcriptomics is crucial for identifying gene expression differences between healthy and cancerous cells.
- This research explores novel therapeutic agents for ovarian cancer.
- Cadmium Sulfide Nanoparticles (CdSNPs) are investigated for their anti-cancer properties.
Purpose Of The Study
- To evaluate the therapeutic potential of Cadmium Sulfide Nanoparticles (CdSNPs) in the PA1 ovarian cancer cell line.
- To analyze the transcriptome-wide effects of CdSNPs treatment on ovarian cancer cells.
- To elucidate the molecular mechanisms underlying CdSNPs' anti-cancer activity.
Main Methods
- RNA-sequencing and transcriptome analysis were performed on PA1 ovarian cancer cells.
- Gene expression data was analyzed to identify differentially expressed genes (DEGs) between treated and control groups.
- Gene Ontology (GO) and KEGG pathway analyses were conducted to understand molecular mechanisms.
Main Results
- A total of 5.42 Gb of high-quality RNA-seq reads were generated.
- 1641 differentially expressed genes (DEGs) were identified with significant statistical thresholds (padj<0.001, log2 foldchange >2).
- Enriched GO terms included apoptotic pathways, extracellular vesicles, programmed cell death, and Ca++ signaling. KEGG analysis highlighted Calcium Signaling, Apoptosis, and TNF signaling pathways.
Conclusions
- CdSNPs demonstrate significant anti-cancer effects on ovarian cancer cells by modulating key biological pathways.
- The study provides insights into CdSNPs as a potential therapeutic strategy for ovarian cancer.
- Further research with diverse cell lines and in vivo models is recommended to advance CdSNPs-based ovarian cancer therapies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...